GI-MAP White Paper
In the last few decades, DNA analysis has transformed the field of microbiology. The Human Microbiome Project and research around the globe have characterized the GI microbiome. More than ever before, we are keenly aware of the health benefits and disease risks brought about by the microorganisms that inhabit the GI tract. Culture techniques, previously the standard, leave up to 50% of bacterial species virtually invisible!
The GI Microbial Assay Plus (GI-MAP™) was designed to assess a patient’s microbiome from a single stool sample, with particular attention to microbes that cause disease or that disrupt normal microbial balance and contribute to perturbations in the GI flora and contribute to illness.
Alterations in gut microbiome have been associated with metabolic diseases such as obesity and type 2 diabetes; however, the changes in bacteria species or genomic composition are not clear.
If you have Celiac Disease, or non-Celiac gluten sensitivity (NCGS), but are still having villi damage or residual symptoms, you may still be getting gluten exposure from hidden sources, including non-dietary sources. This comprehensive list will help you identify potential exposures that you weren’t aware of.